In the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumors

[1] Kitamura H(2006)Early bladder cancer: concept, diagnosis, and management Int J Clin Oncol 11 28-37

[2] Tsukamoto T(1983)Superficial bladder cancer: progression and recurrence J Urol 130 1083-1086

[3] Heney NM(1997)Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients World J Urol 15 84-88

[4] Ahmed S(1995)Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial J Clin Oncol 13 1404-1408

[5] Flanagan MJ(1987)Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma Eur Urol 13 145-149

[6] Frable W(1999)Papillary urothelial neoplasms of low malignant potential Cancer 86 2102-2108

[7] Corder MP(1997)The treated natural history of high risk superficial bladder cancer: 15-year outcome J Urol 158 62-67

[8] Hafermann MD(1999)Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder J Urol 162 1946-1950

[9] Hawkins IR(1995)Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder. The Finnbladder Group J Urol 154 2050-2053

[10] Herr HW(2000)A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma J Urol 164 1768-1775

[1] Kitamura H(2006)Early bladder cancer: concept, diagnosis, and management Int J Clin Oncol 11 28-37

[2] Tsukamoto T(1983)Superficial bladder cancer: progression and recurrence J Urol 130 1083-1086

[3] Heney NM(1997)Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients World J Urol 15 84-88

[4] Ahmed S(1995)Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial J Clin Oncol 13 1404-1408

[5] Flanagan MJ(1987)Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma Eur Urol 13 145-149

[6] Frable W(1999)Papillary urothelial neoplasms of low malignant potential Cancer 86 2102-2108

[7] Corder MP(1997)The treated natural history of high risk superficial bladder cancer: 15-year outcome J Urol 158 62-67

[8] Hafermann MD(1999)Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder J Urol 162 1946-1950

[9] Hawkins IR(1995)Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder. The Finnbladder Group J Urol 154 2050-2053

[10] Herr HW(2000)A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma J Urol 164 1768-1775